Gut Microbiota and Serum Metabolites in Individuals with Class III Obesity Without Type 2 Diabetes Mellitus: Pilot Analysis-Reference-Cited by-同舟云学术

Gut Microbiota and Serum Metabolites in Individuals with Class III Obesity Without Type 2 Diabetes Mellitus: Pilot Analysis

Published:2023-06-01 Issue:5 Volume:21 Page:243-253
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

Kubáňová Libuša¹²^ORCID,Bielik Viktor¹,Hric Ivan²³,Ugrayová Simona¹,Šoltys Katarína⁴⁵,Rádiková Žofia²,Baranovičová Eva⁶,Grendár Marián⁶,Kolisek Martin⁶,Penesová Adela²

Affiliation:

1. Department of Biological and Medical Science, Faculty of Physical Education and Sport, Comenius University in Bratislava, Bratislava, Slovakia.

2. Biomedical Center, Institute of Clinical and Translational Research, Slovak Academy of Sciences, Bratislava, Slovakia.

3. Department of Molecular Biology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia.

4. Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia.

5. Comenius University Science Park, Comenius University in Bratislava, Bratislava, Slovakia.

6. Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/met.2022.0071

Reference59 articles.

1. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

2. Association between Class III Obesity (BMI of 40–59 kg/m2) and Mortality: A Pooled Analysis of 20 Prospective Studies

3. Factors associated with progression of different prediabetic status to Diabetes: A Community-based cohort study

4. Associations of prediabetes with all-cause and cardiovascular mortality: A meta-analysis

5. Ethnic variations in diabetes and prediabetes prevalence and the roles of insulin resistance and β-cell function: The CARRS and NHANES studies